Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118456

Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

P D Ponath, S Qin, D J Ringler, I Clark-Lewis, J Wang, N Kassam, H Smith, X Shi, J A Gonzalo, W Newman, J C Gutierrez-Ramos, and C R Mackay

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Ponath, P. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Qin, S. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Ringler, D. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Clark-Lewis, I. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Wang, J. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Kassam, N. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Smith, H. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Shi, X. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Gonzalo, J. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Newman, W. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Gutierrez-Ramos, J. in: JCI | PubMed | Google Scholar

LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.

Find articles by Mackay, C. in: JCI | PubMed | Google Scholar

Published February 1, 1996 - More info

Published in Volume 97, Issue 3 on February 1, 1996
J Clin Invest. 1996;97(3):604–612. https://doi.org/10.1172/JCI118456.
© 1996 The American Society for Clinical Investigation
Published February 1, 1996 - Version history
View PDF
Abstract

The CC chemokine eotaxin, identified in guinea pigs and also recently in mice, may be a key element for the selective recruitment of eosinophils to certain inflamed tissues. Using a partial mouse eotaxin CDNA probe, the human eotaxin gene was cloned and found to be 61.8 and 63.2% identical at the amino acid level to guinea pig and mouse eotaxin. Human eotaxin protein was a strong and specific eosinophil chemoattractant in vitro and was an effective eosinophil chemoattractant when injected into the skin of a rhesus monkey. Radiolabeled eotaxin was used to identify a high affinity receptor on eosinophils (0.52 nM Kd), expressed at 4.8 x 10(4) sites per cell. This receptor also bound RANTES and monocyte chemotactic protein-3 with lower affinity, but not macrophage inflammatory protein-1 alpha. Eotaxin could desensitize calcium responses of eosinophils to RANTES and monocyte chemotactic protein-3, although RANTES was able to only partially desensitize eosinophil calcium responses to eotaxin. Immunohistochemistry on human nasal polyp with antieotaxin mAbs showed that certain leukocytes as well as respiratory epithelium were intensely immunoreactive, and eosinophil infiltration occurred at sites of eotaxin upregulation. Thus eotaxin in humans is a potent and selective eosinophil chemoattractant that is expressed by a variety cell types in certain inflammatory conditions.

Version history
  • Version 1 (February 1, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts